← FDA DRUG APPROVALS

FDA ANDA · ANDA061764

VELOSEF

Sponsor: APOTHECON

APPLICATION
ANDA061764
TYPE
ANDA
ORIGINAL APPROVAL
1974-08-19
LATEST ACTION
1993-07-08
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Discontinued

Products

VELOSEFDiscontinued
CEPHRADINE 250MG · CAPSULE · ORAL
VELOSEFDiscontinued
CEPHRADINE 500MG · CAPSULE · ORAL

Approval history

1993-07-08Manufacturing (CMC) · Supplement 25AP
1993-07-08Manufacturing (CMC) · Supplement 26AP
1993-07-08Manufacturing (CMC) · Supplement 24AP
1988-03-24Manufacturing (CMC) · Supplement 23AP
1974-08-19OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →